Development of Secondary Cancers in Pre- vs Post-ICI Eligibility Periods for Metastatic Cancers

JAMA Network Open 2026 Open access

Read full text
Authors: Athena Li, Jiyeong Kim, Thet Su Win, Michael L. Chen
DOI: 10.1001/jamanetworkopen.2025.57807
Cited by: 2
References: 6

Abstract

This cohort study investigates incidence of secondary primary cancers before vs after approval of immune checkpoint inhibitors (ICIs) among patients with metastatic cancers.

Fields of Study & Subjects

Multiple and Secondary Primary Cancers Cancer Immunotherapy and Biomarkers Cancer Diagnosis and Treatment

Publication details

Journal / source
JAMA Network Open
Publisher
American Medical Association (AMA)
Volume
9
Issue
2
Pages
e2557807–e2557807
Publication date
4 February 2026
Language
EN